NDC 42291-036 – Lisdexamfetamine Dimesylate
Lisdexamfetamine Dimesylate 20 mg/1 · Capsule · Oral
Product NDC42291-036
Product details
- Brand name
- Lisdexamfetamine Dimesylate
- Generic name
- Lisdexamfetamine
- Labeler
- AvKARE
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA202830
- Marketed since
- June 4, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Lisdexamfetamine Dimesylate 20 mg/1
Uses, dosage, side effects and warnings for Lisdexamfetamine dimesylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-036-90 | 90 CAPSULE in 1 BOTTLE (42291-036-90) | Jun 4, 2025 |
Other Lisdexamfetamine dimesylate products
- 47781-562 Lisdexamfetamine Dimesylate 10 mg/1 · Capsule · Alvogen Inc.
- 47781-563 Lisdexamfetamine Dimesylate 20 mg/1 · Capsule · Alvogen Inc.
- 47781-565 Lisdexamfetamine Dimesylate 40 mg/1 · Capsule · Alvogen Inc.
- 47781-566 Lisdexamfetamine Dimesylate 50 mg/1 · Capsule · Alvogen Inc.
- 47781-564 Lisdexamfetamine Dimesylate 30 mg/1 · Capsule · Alvogen Inc.
- 47781-567 Lisdexamfetamine Dimesylate 60 mg/1 · Capsule · Alvogen Inc.
- 47781-568 Lisdexamfetamine Dimesylate 70 mg/1 · Capsule · Alvogen Inc.
- 60687-940 Lisdexamfetamine Dimesylate 60 mg/1 · Capsule · American Health Packaging
- 60687-896 Lisdexamfetamine Dimesylate 20 mg/1 · Capsule · American Health Packaging
- 60687-907 Lisdexamfetamine Dimesylate 30 mg/1 · Capsule · American Health Packaging
- 60687-929 Lisdexamfetamine Dimesylate 50 mg/1 · Capsule · American Health Packaging
- 60687-918 Lisdexamfetamine Dimesylate 40 mg/1 · Capsule · American Health Packaging